Oncologists' and urologists' preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment.

• Tác giả: Rituparna Bhattacharya, Cooper Bussberg, Shawna R Calhoun, Kentaro Imai, Kelley Myers, Cathy Anne Pinto, Christine Poulos, Caroline Vass
• Ngôn ngữ: eng
• Ký hiệu phân loại: 617.764 *Diseases of lacrimal apparatus
• Thông tin xuất bản: England : Future oncology (London, England) , 2025
• Bộ sưu tập: NCBI
• ID: 690862

Tóm tắt

INTRODUCTION: To quantify physicians' preferences for adjuvant renal cell carcinoma (RCC) treatments. MATERIALS AND METHODS: A discrete-choice experiment was administered online to board-certified/eligible physicians. Physicians chose between pairs of hypothetical adjuvant therapies for a high-risk patient who had recently undergone a radical nephrectomy. Data were analyzed using random-parameters logit and latent-class models. RESULTS: Physicians ( CONCLUSIONS: Most physicians in this study would recommend adjuvant therapy to a typical high-risk postnephrectomy RCC patient.